NewslettersImmunology of Infectious Disease NewsNasal Administration of Anti-CD3 mAb (Foralumab) Downregulates NKG7 and Increases TGFB1 and GIMAP7 Expression in T Cells in Subjects with COVID-19By Laurisa Dohm - March 22, 20230268Using serum proteomics and RNA-sequencing, the authors investigated the immune changes in patients treated with nasal Foralumab.[Proceedings Of The National Academy Of Sciences Of The United States Of America]Full Article